2025年
- Identification of the Lynch syndrome and Lynch-like syndrome specific somatic mutations in microsatellite instability-high colorectal cancer cases.
Ofuchi T, Hirose K, Hosoda K, Ikehara T, Higuchi S, Tsujimoto A, Wada A, Tamaoka Y, Tsuda Y, Otsu H, Yonemura Y, Iwatsuki M, Mimori K.
Surg Today. 2025 Dec 24. doi: 10.1007/s00595-025-03212-w. Online ahead of print.PMID: 41441884
- Identification of the novel therapeutic target gene SLC12A9, which determines the prognosis of patients with colorectal cancer.
Yonemura Y, Ofuchi T, Nakano T, Higuchi S, Kawata K, Ikehara T, Omachi K, Tsujimoto A, Hirose K, Shibuta S, Ando Y, Hu Q, Otsu H, Yoshizumi T, Mimori K.
Surg Today. 2025 Dec 22. doi: 10.1007/s00595-025-03214-8. Online ahead of print.PMID: 41428057
- Genomic and transcriptomic landscape of carcinogenesis in patients with gastric adenocarcinoma and proximal polyposis of the stomach (GAPPS).
Matsumoto C, Takahashi KK, Iwatsuki M, Yasuda-Yoshihara N, Niida A, Yamashita K, Morinaga T, Eto K, Iwagami S, Ida S, Yano H, Komohara Y, Miyamoto Y, Masuda T, Tanaka Y, Mimori K, Baba H.
Proc Natl Acad Sci U S A. 2025 Nov 4;122(44):e2427133122. doi: 10.1073/pnas.2427133122.PMID: 41171849
- Epigenetic Regulation of G6PD Drives Metabolic Reprogramming in Intrahepatic Cholangiocarcinoma.
Nakano Y, Tanaka M, Sakamoto T, Hashimoto M, Tobo T, Saito H, Abe T, Ikehara T, Ofuchi T, Kawata K, Masuda T, Ogino T, Uemura M, Eguchi H, Doki Y, Mimori K.
Cancer Sci. 2025 Dec;116(12):3352-3366. doi: 10.1111/cas.70202.PMID: 41054380
- Case Report: Perioperative Management of a Patient with Glycogen Storage Disease Type IXd.
Kawata K, Otsu H, Hu Q, Tsuda Y, Nagao Y, Yonemura Y, Masuda T, Yoshizumi T, Mimori K.
Surg Case Rep. 2025;11(1):25-0239. doi: 10.70352/scrj.cr.25-0239.PMID: 40923014
- Repeated lymph-node recurrences after radical endoscopic submucosal dissection in a patient of esophageal squamous cell carcinoma, judged as pT1a-LPM: a case report and literature review.
Hirose K, Sadanaga N, Kato S, Yoshimura D, Sokabe Y, Sasaki S, Honbo T, Tsuda Y, Matsuura H, Mimori K.
Clin J Gastroenterol. 2025 Aug 21. doi: 10.1007/s12328-025-02206-y. Online ahead of print.PMID: 40835809
- Cytotoxic Anti-tumor Drugs and Tumor-Associated Macrophages Synergistically Surge PD-L1 Expression in Esophageal Squamous Cell Carcinoma.
Hirose K, Otsu H, Masuda T, Saeki H, Tobo T, Hosoda K, Matsumoto C, Tatsumi T, Ikehara T, Ofuchi T, Higuchi S, Abe T, Nakano Y, Hashimoto M, Nakanoko T, Oki E, Yoshizumi T, Mimori K.
Ann Surg Oncol. 2025 Jul 6. doi: 10.1245/s10434-025-17710-1. Online ahead of print.PMID: 40619486
- VPS45 promotes the progression of hepatocellular carcinoma by recycling β1 integrin to the cell membrane via the endocytic pathway.
Ofuchi T, Otsu H, Hosoda K, Ikehara T, Tsujimoto A, Higuchi S, Shibuta S, Ono Y, Hirose K, Tsuda Y, Yonemura Y, Masuda T, Hayashi H, Iwatsuki M, Mimori K.
J Gastroenterol. 2025 Sep;60(9):1157-1173. doi: 10.1007/s00535-025-02278-0. Epub 2025 Jun 20.PMID: 40540066
- Polarity Gene PARD6B Promotes Tumor Growth of Colorectal Cancer via Increasing MYC Expression.
Hirose K, Masuda T, Otsu H, Tobo T, Hosoda K, Abe T, Nakano Y, Hashimoto M, Tatsumi T, Ikehara T, Ofuchi T, Itoyama S, Ando Y, Tsuda Y, Yonemura Y, Sugimachi K, Oki E, Yoshizumi T, Mimori K.
Cancer Sci.2025 Sep;116(9):2507-2522. doi: 10.1111/cas.70119. Epub 2025 Jun 18.PMID: 40533910
- SEC61G promotes colorectal cancer progression by regulating cytosolic Ca2+ concentration.
Higuchi S, Otsu H, Masuda T, Hashimoto M, Nakano Y, Hosoda K, Hirose K, Ikehara T, Ofuchi T, Tsuda Y, Yonemura Y, Uemura M, Eguchi H, Doki Y, Mimori K.
J Gastroenterol. 2025 Sep;60(9):1091-1107. doi: 10.1007/s00535-025-02259-3. Epub 2025 May 25.PMID: 40413702
- Interview with the World Class Authorities Frontiers of Cancer Research: An exclusive interview with Professor Luis Diaz.
Takeda H, Mimori K, Oshima M, Shirabe K, Kitagawa Y.
Ann Gastroenterol Surg. 2025 Mar 3;9(3):401-407. doi: 10.1002/ags3.70003. eCollection 2025 May.PMID: 40385346
- Clinical and Biological Significance of Sodium Channel Modifier 1 as a Component of the Minor Spliceosome in Hepatocellular Carcinoma.
Ofuchi T, Otsu H, Hosoda K, Ikehara T, Higuchi S, Tatsumi T, Omachi K, Tsujimoto A, Hirose K, Tsuda Y, Yonemura Y, Hayashi H, Masuda T, Iwatsuki M, Mimori K.
Ann Surg Oncol. 2025 Jun;32(6):4508-4519. doi: 10.1245/s10434-025-17108-z. Epub 2025 Apr 2.PMID: 40172715
- Laparoscopically resected appendiceal dual tumor composed of goblet cell carcinoma and low-grade mucinous neoplasm: a case report and literature review.
Hirose K, Minami K, Oshiro Y, Taniguchi D, Kajiwara Y, Tsuda Y, Otsu H, Yonemura Y, Mimori K.
Int Cancer Conf J. 2025 Feb 7;14(2):136-142. doi: 10.1007/s13691-025-00748-z. eCollection 2025 Apr.PMID: 40160879
- Programmed Cell Death 10 (PDCD10) Is a Candidate Tumor-associated Gene in Esophageal Squamous Cell Carcinoma.
Hiraki Y, Masuda T, Motomura Y, Tobo T, Saito H, Hirose K, Ofuchi T, Tsuda Y, Otsu H, Yonemura Y, Kai S, Hirakawa M, Ishigami K, Mimori K.
Anticancer Res. 2025 Apr;45(4):1419-1433. doi: 10.21873/anticanres.17527.PMID: 40155014
- SET-binding protein 1 (SETBP1) suppresses cell proliferation in estrogen receptor-positive breast cancer.
Ando Y, Masuda T, Hayashi N, Kosai K, Shibuta S, Ono Y, Taro T, Otsu H, Hisamatsu Y, Yoshizumi T, Mimori K.
Breast Cancer. 2025 May;32(3):457-469. doi: 10.1007/s12282-025-01667-w. Epub 2025 Feb 20.PMID: 39979691
- Interview with Prof. Dr. Jeffrey Drebin, President of the 2024 President Elect of the American Surgical Association.
Mimori K, Fujii T, Sho M, Endo I, Shirabe K, Kitagawa Y.
Ann Gastroenterol Surg. 2024 Nov 22;9(1):24-31. doi: 10.1002/ags3.12882. eCollection 2025 Jan.PMID: 39759979
- Circulating Pre-microRNA-488 in Blood Is a Potential Prognostic Biomarker in Gastric Cancer.
Tsuruda Y, Masuda T, Hiraki Y, Kitagawa M, Shimizu D, Hu Q, Ito S, Otsu H, Kuroda Y, Eguchi H, Ohtsuka T, Natsugoe S, Mimori K.
Anticancer Res. 2025 Jan;45(1):123-133. doi: 10.21873/anticanres.17399.PMID: 39740846